Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm

Kessler Topaz Meltzer & Check, LLP is investigating Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) for potential securities law violations after the company announced disappointing Q2 2026 financial results. Alnylam cut its full-year TTR product sales guidance by approximately $200 million, leading to a stock price drop of over 28%. The firm is encouraging investors who experienced financial losses to contact them to discuss their legal rights.